Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis. Johnson KP Ther Clin Risk Manag. 2010; 6:153-72. Epub 2010 Apr 15. PMID: 20421914. Abstract CommentRecommendBookmarkWatch